The effect of GBA mutations and APOE polymorphisms on Dementia with Lewy Bodies in Ashkenazi Jews

Manuscript Number: 

20-1295R3

Author(s): 
Anat Bar-Shira, Noa Bregman, Mali Gana Weisz, Nir Giladi, Orly Goldstein, Tanya Gurevich, Gitit Kavé, Anat Mirelman, Avi Orr-Urtreger, Yevgenia Rosenblum, Tamara Shiner, Avner Thaler

Disclosures

Anat Bar-Shira

  • Nothing to Disclose

Noa Bregman

  • Nothing to Disclose

Mali Gana Weisz

  • Nothing to Disclose

Nir Giladi

  • Consulting Fees:
    Sionara, NeuroDerm, Pharma2B, Denali, Neuron23, Sanofi-Genzyme, Biogen and Abbvie.
    Lecture Fees:
    Abbvie, Sanofi-Genzyme and Movement Disorder Society.
    Patents/Royalties
    Lysosomal Therapeutics (LTI)
    Grants
    • Agency: 
      Michael J Fox Foundation
      Dates: 
      2020-2025
    • Agency: 
      National Parkinson Foundation
      Dates: 
      2018-2022
    • Agency: 
      European Union
      Dates: 
      2021
    • Agency: 
      Israel Science Foundation
      Dates: 
      2021
    • Agency: 
      Teva
      Dates: 
      2021
    • Agency: 
      NNE program
      Dates: 
      2021
    • Agency: 
      Biogen
      Dates: 
      2021
    • Agency: 
      Ionis
      Dates: 
      2021

Orly Goldstein

  • Nothing to Disclose

Tanya Gurevich

  • Consulting Fees:
    Cytora, Synnerva, Teva, Abbvie, Neuroderm, and Allergan,
    Lecture Fees:
    Medison, Teva

Gitit Kavé

  • Nothing to Disclose

Anat Mirelman

  • Consulting Fees:
    Report serves as a consultant for Neuroderm on topics relating to wearable sensros

Avi Orr-Urtreger

  • Nothing to Disclose

Yevgenia Rosenblum

  • Nothing to Disclose

Tamara Shiner

  • Nothing to Disclose

Avner Thaler

  • Consulting Fees:
    Consulting fees for Abbvie LTD
    Lecture Fees:
    Lecture fees from Abbvie LTD